Prevention and treatment study for new brittle bone fractures
Treatments studied
Part of Bones, joints & muscles, Hormones & metabolism, Injuries & trauma clinical trials.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a new brittle hip fracture or new brittle spine fracture, or a new fracture in another location.
- You are a man or a postmenopausal woman, age 45–90.
- You can move around on your own.
- You do not have other bone diseases (besides osteoporosis) such as Paget’s disease, osteomalacia, or osteogenesis imperfecta.
- You have kidney function that is not severely reduced (GFR 30 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to help adults over 50 who had a recent bone fracture (from a minor fall) get better follow-up care to prevent future fractures. You will work with a nurse or coordinator to connect with your primary care doctor and learn about bone health options.
This study tests a new classification system to help doctors decide the best treatment for spine fractures caused by osteoporosis. It aims to improve pain and mobility by matching treatment to fracture type.
This study tests whether denosumab, a medication given as an injection, can help prevent broken bones in people with type 2 diabetes who are at high risk for fractures. It aims to see if this treatment can strengthen bones and reduce fracture risk.
This study compares two treatment plans for women with osteoporosis to see which one improves hip bone density more. Participants will either get two medications in sequence (romosozumab followed by denosumab) or one medication (zoledronic acid), both given as injections or infusions. The goal is to find a treatment that reduces fracture risk.
This study tests an investigational injection called TST002 to see if it can help strengthen bones in postmenopausal women with osteoporosis or low bone mass. It may help reduce the risk of fractures.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Hear when a new Osteoporotic Fractures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.